UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

They may recommend a combination of therapy drugs and alternative treatments. Yes, you have a say in your cancer treatment, including making the decision to delay treatment or not have treatment ...

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on the appropriate options.

About the Drugs Below is a detailed analysis of ... Treatment of hormone-refractory prostate cancer, Treatment of BRCA1/2 mutated cancers that demonstrates tolerance (resistance) to currently ...

The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...

The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

At the New Mexico Cancer Center in Albuquerque, groundbreaking treatments and compassionate care are changing lives for men facing prostate cancer. With a team of dedicated specialists, their ...

announced today that it has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others, prostate, ovarian, and colorectal cancers. Both of these ...